5052 Proton glutamate symport protein
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Hydrocarbons | 1 | 0.0 | 24× | not tested | |
| Benzenoids | 5 | 0.4 | 12× | not tested | |
| Organic acids and derivatives | 6 | 0.9 | 6.55× | not tested | |
| Lipids and lipid-like molecules | 4 | 0.7 | 6.07× | not tested | |
| Organic nitrogen compounds | 1 | 0.2 | 5.30× | not tested | |
| Organic oxygen compounds | 2 | 1.2 | 1.70× | not tested | |
| Homogeneous metal compounds | 4 | 2.9 | 1.38× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00128 | ASP | Aspartic acid | 84 |
| DB00142 | GLU | Glutamic acid | 12 |
| DB00130 | GLN | L-Glutamine | 6 |
| DB00141 | NAG | N-Acetylglucosamine | 6 |
| DB03796 | PLM | Palmitic Acid | 6 |
| DB00122 | CHT | Choline | 3 |
| DB00133 | SER | Serine | 3 |
| DB00151 | CYS | Cysteine | 3 |
| DB02655 | DAS | D-Aspartic Acid | 3 |
| DB04531 | BCS | S-Benzylcysteine | 3 |
| DB04540 | CLR | Cholesterol | 2 |
| DB00160 | — | Alanine | 1 |
| DB00174 | — | Asparagine | 1 |
| DB13146 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAmetal | SODIUM ION | 123 |
| ASP | ASPARTIC ACID | 93 |
| HGmetal | MERCURY (II) ION | 42 |
| 6OU | [(2~{R})-1-[2-azanylethoxy(oxidanyl)phosphoryl]oxy-3-hexadecanoyloxy-propan-2-yl] (~{Z})-octadec-9-enoate | 16 |
| Y01 | CHOLESTEROL HEMISUCCINATE | 15 |
| 6Z6 | 2-Amino-5,6,7,8-tetrahydro-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-4H-chromene-3-carbonitrile | 14 |
| CLR | CHOLESTEROL | 14 |
| GLN | GLUTAMINE | 14 |
| PC1 | 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 14 |
| DMU | DECYL-BETA-D-MALTOPYRANOSIDE | 10 |
| TB1 | (3S)-3-(BENZYLOXY)-L-ASPARTIC ACID | 10 |
| ALA | ALANINE | 9 |
| 7O9 | (2~{S},3~{S})-2-azanyl-3-[[3-[[4-(trifluoromethyl)phenyl]carbonylamino]phenyl]methoxy]butanedioic acid | 7 |
| GJ0 | (2S)-2-azanyl-4-[[4-[2-bromanyl-4,5-bis(fluoranyl)phenoxy]phenyl]amino]-4-oxidanylidene-butanoic acid | 7 |
| GLU | GLUTAMIC ACID | 7 |
| CYS | CYSTEINE | 6 |
| DAS | D-ASPARTIC ACID | 6 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 6 |
| PLM | PALMITIC ACID | 6 |
| QM5 | (2~{S},3~{S})-2-azanyl-3-[[4-[2-(4-methoxyphenyl)hydrazinyl]phenyl]methoxy]butanedioic acid | 6 |